Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
Status:
Withdrawn
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the ability of epoetin alfa to raise
hemoglobin (Hb) levels in elderly outpatients with unexplained anemia. The secondary
objectives of this study are to assess the ability of epoetin alfa to improve physical
function; cognitive function; and quality of life, and to assess the safety of epoetin alfa
in the study population.